Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 10:40AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.61 Insider Own1.08% Shs Outstand49.52M Perf Week10.28%
Market Cap58.43M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float48.99M Perf Month14.56%
Income-52.05M PEG- EPS next Q- Inst Own4.18% Short Float0.03% Perf Quarter8.26%
Sales2.06B P/S0.03 EPS this Y- Inst Trans-1.17% Short Ratio0.27 Perf Half Y-23.87%
Book/sh-0.96 P/B- EPS next Y- ROA-11.88% Short Interest0.01M Perf Year-63.80%
Cash/sh1.75 P/C0.67 EPS next 5Y- ROE- 52W Range0.97 - 3.36 Perf YTD-23.87%
Dividend Est.- P/FCF- EPS past 5Y10.66% ROI- 52W High-64.88% Beta0.50
Dividend TTM- Quick Ratio0.52 Sales past 5Y58.22% Gross Margin5.56% 52W Low21.64% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.08 EPS Y/Y TTM-4.00% Oper. Margin-2.18% RSI (14)59.61 Volatility9.31% 6.49%
Employees1520 Debt/Eq- Sales Y/Y TTM-0.52% Profit Margin-2.53% Recom1.00 Target Price5.70
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q59.64% Payout- Rel Volume4.02 Prev Close1.10
Sales Surprise- EPS Surprise- Sales Q/Q-9.15% EarningsMay 23 BMO Avg Volume47.55K Price1.18
SMA209.88% SMA504.00% SMA200-21.03% Trades Volume42,151 Change7.27%
Date Action Analyst Rating Change Price Target Change
Apr-15-21Resumed Citigroup Buy $16
Jul-19-24 08:45AM
Jul-17-24 01:31AM
Jun-11-24 03:57AM
May-23-24 08:52AM
02:30AM Loading…
Apr-30-24 02:30AM
Mar-22-24 11:36AM
Mar-21-24 04:47AM
Mar-01-24 04:00AM
Feb-27-24 08:58AM
Dec-01-23 09:20AM
Nov-30-23 01:00AM
Nov-13-23 12:10AM
Aug-31-23 08:09AM
Aug-24-23 02:00AM
05:59AM Loading…
Jul-31-23 05:59AM
Jun-15-23 05:03AM
May-25-23 02:05AM
Mar-27-23 06:26AM
Mar-23-23 05:07AM
Mar-02-23 02:35AM
Feb-16-23 12:33AM
Dec-01-22 02:33AM
Nov-08-22 01:09AM
Sep-23-22 12:30AM
Sep-09-22 05:53AM
Aug-25-22 02:18AM
Aug-08-22 01:19PM
02:26AM Loading…
Aug-05-22 02:26AM
Jun-16-22 03:58AM
May-26-22 04:59AM
May-05-22 01:46PM
Apr-13-22 05:02AM
Mar-17-22 03:20AM
Mar-14-22 07:35AM
Mar-04-22 04:24AM
Mar-01-22 08:55AM
Feb-22-22 03:38AM
Jan-03-22 09:38PM
Nov-22-21 12:14PM
Nov-19-21 12:31AM
Nov-01-21 04:57PM
Oct-28-21 07:00PM
Oct-25-21 07:00AM
Sep-17-21 07:00AM
Sep-07-21 05:00AM
Aug-27-21 02:30AM
Aug-16-21 08:00AM
Aug-13-21 07:16AM
Aug-09-21 07:30AM
Aug-03-21 08:00AM
Jun-18-21 10:09AM
May-19-21 02:17AM
May-12-21 10:10AM
Apr-21-21 08:00AM
Mar-25-21 05:00AM
Mar-18-21 06:10AM
Mar-17-21 06:50AM
Mar-16-21 05:40AM
Feb-05-21 06:00AM
Jan-01-21 03:24AM
Dec-22-20 04:22AM
Nov-29-20 11:42AM
Nov-19-20 05:00AM
Oct-22-20 06:00AM
Oct-19-20 06:50AM
Oct-15-20 05:40PM
Sep-30-20 06:00AM
Sep-23-20 12:53PM
Sep-04-20 06:22AM
Aug-20-20 04:35AM
Jul-31-20 06:00AM
Jul-27-20 06:00AM
May-27-20 03:44PM
May-21-20 04:30AM
May-15-20 11:55AM
May-08-20 06:00AM
May-07-20 05:55AM
May-06-20 05:51AM
May-04-20 06:51AM
Apr-17-20 01:58AM
Mar-27-20 07:30AM
Mar-19-20 08:10AM
Mar-16-20 12:38PM
Mar-12-20 06:00AM
Feb-24-20 03:00AM
Feb-20-20 04:15AM
Feb-11-20 05:00PM
Feb-04-20 06:39AM
Jan-19-20 05:00AM
Jan-17-20 08:00AM
Jan-13-20 05:30AM
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.